Theriva Biologics Inc. (TOVX) — Net Asset Quality Index
Theriva Biologics Inc. (TOVX) has a Net Asset Quality Index of 40.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $38.25 Million minus total liabilities of $22.85 Million yields net assets of $15.40 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Theriva Biologics Inc. carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Theriva Biologics Inc. Net Asset Quality Index Over Time (1993–2025)
This chart shows how Theriva Biologics Inc.'s Net Asset Quality Index has evolved across 31 annual periods from 1993 to 2025. As of March 2026, the index stands at 40.3%, representing net assets of $15.40 Million against total assets of $38.25 Million USD. For live market cap and overall valuation, see market cap of Theriva Biologics Inc..
Annual Net Asset Quality Index for Theriva Biologics Inc. (1993–2025)
The table below presents the year-by-year Net Asset Quality Index for Theriva Biologics Inc. from 1993 to 2025, covering 31 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Theriva Biologics Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 40.2% | $15.38 Million | $38.24 Million | $22.86 Million | ▼ -13.7 pp |
| 2024 | 53.9% | $19.07 Million | $35.35 Million | $16.29 Million | ▼ -18.0 pp |
| 2023 | 71.9% | $39.70 Million | $55.22 Million | $15.52 Million | ▼ -4.0 pp |
| 2022 | 75.9% | $54.56 Million | $71.86 Million | $17.30 Million | ▼ -17.0 pp |
| 2021 | 93.0% | $65.41 Million | $70.36 Million | $4.96 Million | ▲ +30.4 pp |
| 2020 | 62.5% | $5.26 Million | $8.41 Million | $3.15 Million | ▼ -4.1 pp |
| 2019 | 66.6% | $11.49 Million | $17.23 Million | $5.75 Million | ▼ -21.1 pp |
| 2018 | 87.8% | $26.45 Million | $30.14 Million | $3.69 Million | ▲ +105.9 pp |
| 2017 | -18.1% | $-3.41 Million | $18.84 Million | $22.25 Million | ▼ -28.1 pp |
| 2016 | 10.0% | $2.25 Million | $22.50 Million | $20.25 Million | ▼ -38.6 pp |
| 2015 | 48.6% | $15.00 Million | $30.84 Million | $15.84 Million | ▼ -1.3 pp |
| 2014 | 49.9% | $9.56 Million | $19.14 Million | $9.59 Million | ▼ -43.8 pp |
| 2013 | 93.7% | $15.23 Million | $16.26 Million | $1.03 Million | ▼ -3.4 pp |
| 2012 | 97.1% | $13.03 Million | $13.42 Million | $395.00K | ▲ +2.6 pp |
| 2011 | 94.4% | $7.06 Million | $7.48 Million | $417.00K | ▲ +7.4 pp |
| 2010 | 87.0% | $3.58 Million | $4.11 Million | $532.48K | ▲ +0.1 pp |
| 2009 | 87.0% | $3.54 Million | $4.08 Million | $531.43K | ▼ -4.6 pp |
| 2008 | 91.6% | $6.76 Million | $7.39 Million | $620.72K | ▲ +4.0 pp |
| 2007 | 87.6% | $11.95 Million | $13.63 Million | $1.69 Million | ▼ -6.6 pp |
| 2006 | 94.2% | $11.79 Million | $12.52 Million | $729.02K | ▲ +143.1 pp |
| 2005 | -48.9% | $-703.84K | $1.44 Million | $2.14 Million | ▲ +966.9 pp |
| 2002 | -1015.8% | $-15.39 Million | $1.51 Million | $16.90 Million | ▼ -573.9 pp |
| 2001 | -441.9% | $-9.09 Million | $2.06 Million | $11.14 Million | ▼ -434.3 pp |
| 2000 | -7.6% | $-413.72K | $5.45 Million | $5.86 Million | ▼ -20.9 pp |
| 1999 | 13.3% | $671.07K | $5.05 Million | $4.38 Million | ▼ -10.8 pp |
| 1998 | 24.1% | $700.00K | $2.90 Million | $2.20 Million | ▲ +338.4 pp |
| 1997 | -314.3% | $-2.20 Million | $700.00K | $2.90 Million | ▼ -375.0 pp |
| 1996 | 60.7% | $1.70 Million | $2.80 Million | $1.10 Million | ▼ -21.1 pp |
| 1995 | 81.8% | $1.80 Million | $2.20 Million | $400.00K | ▲ +206.8 pp |
| 1994 | -125.0% | $-500.00K | $400.00K | $900.00K | ▼ -213.9 pp |
| 1993 | 88.9% | $1.60 Million | $1.80 Million | $200.00K | — |